Movement Disorders · 2003 · 221 citations · 25 references
MedicineNeurologyNuclear MedicineCardiac Nuclear MedicineDiagnostic ImagingNeuroradiologyAutonomic Nervous System TestingCardiac AssessmentCardiac ImagingCardiac Nuclear ImagingMultiple System Atrophy ImagingMyocardial Tracer Uptake AssessmentMyocardial Uptake QuantificationPostganglionic Sympathetic DenervationQuantitative Uptake RatiosRegional Uptake AnalysisSingle-photon Emission Computed Tomography Tracer UptakeSympathetic Nervous System Dysfunction
[(123)I]Metaiodobenzylguanidine ([(123)I]MIBG) cardiac scintigraphy could be helpful to differentiate Parkinson's disease (PD) from multiple system atrophy (MSA), demonstrating that, in PD with autonomic failure but not in MSA, there is a myocardial postganglionic sympathetic dysfunction. To investigate whether this method is more sensitive than standard autonomic testing to detect early involvement of sympathetic cardiac efferent, we analyse MIBG myocardial uptake in 8 PD patients with normal autonomic testing (nondysautonomia PD group, NDPD) in comparison with 10 PD patients with abnormal autonomic testing (dysautonomia PD group, DPD) and 10 MSA patients. Global MIBG uptake was assessed using the ratio of [(123)I]MIBG uptake in the heart to the upper mediastinum (H/M) on planar scintigraphic data. Regional MIBG uptake was determined on two single photon emission tomography scans in regions of the left ventricle. The mean H/M ratios were significantly different among the three groups (P < 0.0001). H/M ratios of both NDPD and DPD patients groups (H/M = 1.83 +/- 0.50 and 1.24 +/- 0.40, respectively) were significantly lower than in MSA patients (H/M = 2.52 +/- 0.60). However, in NDPD patients, H/M was significantly higher than in DPD patients. When compared to MSA patients, NDPD patients showed a regional reduction in MIBG uptake in all left ventricle regions markedly in the apex and the inferior wall. Our results suggest that MIBG myocardial scintigraphy (analysis of both H/M ratio and regional MIBG uptake) may be more sensitive than standard autonomic testing for the early detection of silent autonomic dysfunction in PD.
25
Margaret M. Hoehn, Melvin D. Yahr · Neurology · 1967 · 12K citations · Full text
The Value of Cardiovascular Autonomic Function Tests: 10 Years Experience in Diabetes
D J Ewing, Christopher Martyn, Robert J. Young et al. · Diabetes Care · 1985 · 1.4K citations
Improved accuracy of clinical diagnosis of Lewy body Parkinson’s disease
Andrew Hughes, Susan E. Daniel, Andrew J. Lees · Neurology · 2001 · 807 citations
Medicine, Neurology, Neuroscience +13
Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure.
Pascal Merlet, Héric Valette, J.L. Dubois-Randé et al. · PubMed · 1992 · 583 citations
Cardiac Sympathetic Denervation in Parkinson Disease
David S. Goldstein · Annals of Internal Medicine · 2000 · 368 citations
Medicine, Cardiology, Neurology +17